AHA: Program Cuts Heart Failure Readmits But May Up Mortality

Share this content:
AHA: Program Cuts Heart Failure Readmits But May Up Mortality
AHA: Program Cuts Heart Failure Readmits But May Up Mortality

MONDAY, Nov. 13, 2017 (HealthDay News) -- Implementation of the Hospital Readmissions Reduction Program (HRRP) is associated with a reduction in readmissions for patients with heart failure but also with an increase in mortality, according to a study published online Nov. 12 in JAMA Cardiology to coincide with the American Heart Association's Scientific Sessions, being held Nov. 11 to 15 in Anaheim, California.

Ankur Gupta, M.D., Ph.D., from Harvard Medical School in Boston, and colleagues examined the correlation of the HRRP with readmission and mortality outcomes in patients hospitalized for heart failure. Data were included for 115,245 Medicare beneficiaries across 416 U.S. hospital sites participating in the American Heart Association Get With The Guidelines-Heart Failure (GWTG-HF) registry.

The researchers found that there was a decrease in the 30-day risk-adjusted readmission rate, from 20 percent before HRRP implementation to 18.4 percent in the HRRP penalties phase (hazard ratio, 0.91). In contrast, an increase was seen in the 30-day risk-adjusted mortality rate, from 7.2 percent before HRRP implementation to 8.6 percent in the HRRP penalties phase (hazard ratio, 1.18). A similar pattern was seen for the one-year risk-adjusted readmission and mortality rates, with a decline in the readmission rate from 57.2 to 56.3 percent (hazard ratio, 0.92) and an increase in the mortality rate from 31.3 to 36.3 percent (hazard ratio, 1.1).

"If confirmed, this finding may require reconsideration of the HRRP in heart failure," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry, and the study was partially funded by the GWTG-HF program, which received funding from pharmaceutical and medical device companies.

Abstract/Full Text
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Progress in HIV Prevention Has Stalled in the United States

CDC: Progress in HIV Prevention Has Stalled in ...

Agency says effective HIV prevention, treatment not reaching those who could most benefit

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in Children

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in ...

All children with sustained unresponsiveness ingested concentrated and baked egg

Prenatal Vitamin Intake in Early Pregnancy May Cut Autism Risk

Prenatal Vitamin Intake in Early Pregnancy May Cut ...

ASD risk down for children whose mothers took prenatal vitamins during first month of pregnancy

is free, fast, and customized just for you!




Already a member?

Sign In Now »